Literature DB >> 20348518

Antibody response from whole-cell pertussis vaccine immunized Brazilian children against different strains of Bordetella pertussis.

Alexandre Pereira1, Aparecida S Pietro Pereira, Célio Lopes Silva, Gutemberg de Melo Rocha, Ivo Lebrun, Osvaldo A Sant'Anna, Denise V Tambourgi.   

Abstract

Bordetella pertussis is a gram-negative bacillus that causes the highly contagious disease known as pertussis or whooping cough. Antibody response in children may vary depending on the vaccination schedule and the product used. In this study, we have analyzed the antibody response of cellular pertussis vaccinated children against B. pertussis strains and their virulence factors, such as pertussis toxin, pertactin, and filamentous hemagglutinin. After the completion of the immunization process, according to the Brazilian vaccination program, children serum samples were collected at different periods of time, and tested for the presence of specific antibodies and antigenic cross-reactivity. Results obtained show that children immunized with three doses of the Brazilian whole-cell pertussis vaccine present high levels of serum antibodies capable of recognizing the majority of the components present in vaccinal and non-vaccinal B. pertussis strains and their virulence factors for at least 2 years after the completion of the immunization procedure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348518      PMCID: PMC2844572          DOI: 10.4269/ajtmh.2010.09-0486

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Biotechnology       Date:  1992

2.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Authors:  Thuan Le; James D Cherry; Swei-Ju Chang; Maria Deloria Knoll; Martin L Lee; Steve Barenkamp; David Bernstein; Robert Edelman; Kathryn M Edwards; David Greenberg; Wendy Keitel; John Treanor; Joel I Ward
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

Review 3.  Pertussis: current concepts of pathogenesis and prevention.

Authors:  E L Hewlett
Journal:  Pediatr Infect Dis J       Date:  1997-04       Impact factor: 2.129

4.  A simple chemically defined medium for the production of phase I Bordetella pertussis.

Authors:  D W Stainer; M J Scholte
Journal:  J Gen Microbiol       Date:  1970-10

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study.

Authors:  P García-Corbeira; R Dal-Ré; L Aguilar; J García-de-Lomas
Journal:  Vaccine       Date:  2000-04-28       Impact factor: 3.641

7.  Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children.

Authors:  N N Tran Minh; K Edelman; Q He; M K Viljanen; H Arvilommi; J Mertsola
Journal:  Vaccine       Date:  1998-10       Impact factor: 3.641

8.  Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.

Authors:  E Leininger; M Roberts; J G Kenimer; I G Charles; N Fairweather; P Novotny; M J Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

9.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.

Authors:  L Gustafsson; H O Hallander; P Olin; E Reizenstein; J Storsaeter
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

Review 10.  What is new in pertussis?

Authors:  Ellen S Bamberger; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2007-08-01       Impact factor: 3.183

View more
  1 in total

1.  Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil.

Authors:  Lourdes R A Vaz-de-Lima; Ana Paula S Sato; Lucia C Pawloski; Eder G Fernandes; Gowrisankar Rajam; Helena K Sato; Divya Patel; Han Li; Euclides A de Castilho; Maria Lucia Tondella; Jarad Schiffer
Journal:  Vaccine X       Date:  2021-02-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.